SonoThera raises $125M for non-viral gene therapy approach

Ken Greenberg, SonoThera CEO June 10, 2026 11:23 AM EDTUpdated 12:28 PM FinancingCell/Gene Tx SonoThera rais­es $125M for non-vi­ral gene ther­a­py ap­proach Nicole DeFeudis Senior Reporter SonoThera has se­cured $125 mil­lion to take its ul­tra­sound-based gene ther­a­py tech­nol­o­gy in­to the clin­ic. The com­pa­ny is fo­cused on two lead pro­grams in Duchenne … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER